Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Citi Research's U.S. Equity Strategy Large-Cap Recommendation List
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Novartis Buys Gene Therapy Developer Kate for up to $1.1B
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields